The CONNECT trial reveals how CGM improves A1C and time in range in type 2 diabetes patients not using insulin. Explore the findings and implications.
Read More »The CONNECT trial reveals how CGM improves A1C and time in range in type 2 diabetes patients not using insulin. Explore the findings and implications.
Read More »